Jean-Paul Gaudilliere is based at the Max Planck Institute for the History of Science. Publications include Living Properties: Making Knowledge and Controlling Ownership in the History of Biology, co-ed, (2009) and 'How Pharmaceuticals became Patentable: The Production and Appropriation of Drugs in the Twentieth Century', History and Technology (2008). Ulrike Thoms is a senior researcher at the Institute for the History of Medicine and Ethics in Medicine, Berlin. Among her many publications is a major study on the food in German hospitals and prisons, and recent articles include 'Consuming Bodies: The Commodification and Technification of Slenderness in the Twentieth Century', from Globalizing Beauty: Consumerism and Body Aesthetics in the Twentieth Century (2013).

• List of Contributors, List of Figures and Tables, Acknowledgements, Introduction – Jean-Paul Gaudillière and Ulrike Thomas, Part I: Marketing Research and Innovation, Part II: Marketing Tools and Visual Practices, Part III: In-House Biomedical Research and Marketing, Notes, Index

Jean-Paul Gaudilliere is based at the Max Planck Institute for the History of Science. Publications include Living Properties: Making Knowledge and Controlling Ownership in the History of Biology, co-ed, (2009) and 'How Pharmaceuticals became Patentable: The Production and Appropriation of Drugs in the Twentieth Century', History and Technology (2008). Ulrike Thoms is a senior researcher at the Institute for the History of Medicine and Ethics in Medicine, Berlin. Among her many publications is a major study on the food in German hospitals and prisons, and recent articles include 'Consuming Bodies: The Commodification and Technification of Slenderness in the Twentieth Century', from Globalizing Beauty: Consumerism and Body Aesthetics in the Twentieth Century (2013).

• List of Contributors, List of Figures and Tables, Acknowledgements, Introduction – Jean-Paul Gaudillière and Ulrike Thomas, Part I: Marketing Research and Innovation, Part II: Marketing Tools and Visual Practices, Part III: In-House Biomedical Research and Marketing, Notes, Index